𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Local measures for the reduction of drug emergency risks and drug mortality risks

✍ Scribed by H.-Jochen Zenker; Christel Zenker; Peter Lang


Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
262 KB
Volume
62
Category
Article
ISSN
0379-0738

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The risks and benefits of drug therapy
✍ George Destevens πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 609 KB

There is no such thing as an absolutely safe drug. There never was, and I doubt that there will ever be one. Considering this opening statement, I would like to take you through an historical trip on the evolution of drug therapy, what the risks and benefits are, and what the new era of biotechnolog

Nifedipine and mortality risk in the eld
✍ Colleen J. Maxwell; David B. Hogan; Norman R. C. Campbell; Erika M. Ebly πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 138 KB

## Purpose: This study examines the risk of all-cause and cardiac-related mortality associated with calcium channel blockers (ccbs) and other antihypertensives/diuretics compared with beta-blockers among an elderly cohort. we explored variations in mortality risk according to ccb formulation, dose

Anti-inflammatory drugs, analgesics and
✍ C. R. Morris; I. M. Harvey; W. S. L. Stebbings; C. T. M. Speakman; H. J. Kennedy πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## Abstract ## Background Acute perforated colonic diverticular disease has a mortality rate of up to 30 per cent, but little is known about its aetiology. The aim of this study was to test the hypothesis that three classes of drugs, namely non-steroidal anti-inflammatory drugs (NSAIDs), opioid an

Use of Oral Xanthines in the Elderly and
✍ Eric Van Ganse; Walter Vincken; Hubert Leufkens; Pierre Ernst πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

Information from a Drug Dispensing Database Table 1 Ð Concomitant use of oral xanthines (OX) and medications from four interacting classes (IC), in ambulatory elderly patients (n 995) Risk of Ca-channel Fluoroquinolones Macrolides H 2 -receptor interaction blockers antagonists % OX-users 30.1 19.0 1